Excelsior Biopharma

Excelsior Biopharma PEG

The PEG Ratio (Price/Earnings-to-Growth) of Excelsior Biopharma (6496.TWO) as of Oct 28, 2026 is 0.47. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.23 — a change of 101.17% (higher).

PEG

0.47

YoY

101.17%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Excelsior Biopharma is 2020 0.47 . PEG Ratio (Price/Earnings-to-Growth) of Excelsior Biopharma was 2019 0.23 . It decreases by 101.17% higher compared to the previous year.

The Excelsior Biopharma PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2014
0.11 TWD
Jan 1, 2015
0.11 TWD
Jan 1, 2016
0.09 TWD
Jan 1, 2017
0.06 TWD
Jan 1, 2018
0.07 TWD
Jan 1, 2019
0.23 TWD
Jan 1, 2020
0.47 TWD
The Excelsior Biopharma PEG history
YEARPEGYoY
0.47+101.17%
0.23+212.38%
0.07+26.08%
0.06-35.48%
0.09-20.58%
0.11+7.41%
0.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

PEG Ratio (Price/Earnings-to-Growth) of Excelsior Biopharma is 0.47 in 2020.

PEG Ratio (Price/Earnings-to-Growth) of Excelsior Biopharma changed from 0.23 to 0.47, representing a 101.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Excelsior Biopharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Excelsior Biopharma

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Excelsior Biopharma